about
Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1Effect of hookworm infection on wheat challenge in celiac disease--a randomised double-blinded placebo controlled trialRole of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation.Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantationSOCS3 regulates graft-versus-host disease.Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection.Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome.CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease.Adiponectin and its receptors in patients with chronic hepatitis C.Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation.Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migrationInteraction of non-alcoholic fatty liver disease with other liver diseases.Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection.Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C.Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of lifeNonalcoholic fatty liver disease: is all the fat bad?Macrophage secretory products induce an inflammatory phenotype in hepatocytesStereological Analysis of Liver Biopsy Histology Sections as a Reference Standard for Validating Non-Invasive Liver Fat Fraction Measurements by MRIDeletion of Wntless in myeloid cells exacerbates liver fibrosis and the ductular reaction in chronic liver injury.Steatosis: co-factor in other liver diseases.Multiplex Serum Protein Analysis Identifies Novel Biomarkers of Advanced Fibrosis in Patients with Chronic Liver Disease with the Potential to Improve Diagnostic Accuracy of Established BiomarkersIdentification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma.Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others.Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after alpha-galactosylceramide administration.Independent effects of diet and exercise training on fat oxidation in non-alcoholic fatty liver disease.Detection of clonally expanded hepatocytes in chimpanzees with chronic hepatitis B virus infection.Ductular reactions in human liver: diversity at the interface.The serrated pathway to colorectal carcinoma: current concepts and challenges.BMI but not stage or etiology of nonalcoholic liver disease affects the diagnostic utility of carbohydrate-deficient transferrin.Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion.Pathology of the liver sinusoids.Critical appraisal of the diagnosis of the sessile serrated adenoma.Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma.The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease.Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease.Inconsistent hepatic antifibrotic effects with the iron chelator deferasirox.The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease.Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.Corruption of dendritic cell antigen presentation during acute GVHD leads to regulatory T-cell failure and chronic GVHD.
P50
Q27478313-81732EE4-13C7-427F-AED4-6B77ECB31D9BQ28742115-E4CC6539-1F5C-4C75-BF39-7F5EE167C880Q32186756-0CC86605-AD58-477C-B41B-E3BB6A871091Q33758318-73D20D98-844D-4880-B987-889E74F1FC8BQ34022451-43EA66B0-4A79-4BFE-A073-63B419663881Q34031257-1B3F6371-714A-4BD2-81FE-CC3B79C81930Q34205748-605BFF9A-47D9-45B2-9754-607185CE863EQ34311645-966667EA-1321-4393-A10B-82444F43F57BQ34448049-AB126BAE-2E11-4748-AFA5-682415C27F2DQ34522502-94F32774-6092-498F-A89C-C1E572320804Q34637842-0FA919D1-E56E-48ED-8838-5716737A145FQ34750592-940AFBBE-25D5-4129-86F8-D817D0056F5DQ34983530-752FB3B8-8125-45B0-874F-41BA3D66A686Q35548839-404E0274-6188-4F8A-8925-274852CFD04EQ35594723-E53F3884-1E17-45BC-888C-C2669773140BQ35596306-FAFDE598-E80F-4E49-ACCC-92B93D3E8382Q35746690-9AE2A7D8-937F-4EFB-ADAC-2322B0972925Q35904291-90F997AB-850B-4014-B412-BC15CD502103Q36097591-3EE556A3-4BB5-4F85-A9AC-E9E5F2D15349Q36163662-0ED2E57E-09A3-4CBC-9DA3-AAA4F825C7B8Q36165987-74ED767E-4655-4512-9A04-FE5B1123B15FQ36197398-9AC7F771-D02E-4394-9097-B6FFA74F23BFQ36725997-54FA555F-5A7C-4117-B5B2-E0E629BBFA07Q36838605-FEE87639-6C06-4228-8824-0403A8567E64Q37237496-9141282C-0833-4846-9A4B-B2F266B5053AQ37285170-3082162B-5AEB-4B0C-9460-93B84281792CQ37333714-85FCB6DE-DBF9-402E-8CCF-E7D2DB0910E9Q37943729-6DDD53D6-6ACB-4DA5-9F8D-C07811A68469Q38075894-4C69400B-B840-4D96-90AD-4629C87982CAQ38123193-AE43BB9C-AA6B-48DC-9B28-3378AD3D360FQ38169443-75255EDA-E28E-4411-9187-02F9855B0613Q38176084-E4A604F2-327A-45C7-98B2-2017B9D5663CQ38178013-65AAF442-D141-4444-AC7E-1AFE92D3BB4DQ38328606-DB02DE95-1775-480B-91DA-58F5160D7E4EQ38535634-65E74C94-34F6-4BDD-8EA3-21078B998820Q38956502-7C2165D3-6657-49C1-B53D-D26037A9DA1DQ38962101-2B33DB78-AC3D-4578-9E23-EE0C1DDCF8E1Q39311652-8C64AD86-AC1A-423A-966A-5F21A241B546Q39580319-53042A96-7742-41CC-B6B9-78A26D391528Q39659749-73A34633-2AE4-423E-A358-B3EBA5C04BC5
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andrew D. Clouston
@ast
Andrew D. Clouston
@en
Andrew D. Clouston
@es
Andrew D. Clouston
@nl
type
label
Andrew D. Clouston
@ast
Andrew D. Clouston
@en
Andrew D. Clouston
@es
Andrew D. Clouston
@nl
prefLabel
Andrew D. Clouston
@ast
Andrew D. Clouston
@en
Andrew D. Clouston
@es
Andrew D. Clouston
@nl
P1053
E-7199-2011
P106
P1153
34569395100
P21
P31
P3829
P496
0000-0002-9601-7952